Effects of experimental coarctation of the aorta on atheroma in sheep.

F. Magarey,B. Roser,W. Stehbens,A. Sharp

DOI: https://doi.org/10.1002/PATH.1700900114

1965-07-01

The Journal of Pathology and Bacteriology

Abstract:

What problem does this paper attempt to address?

Terminal proliferation and synaptogenesis following partial deafferentation: The reinnervation of the inner molecular layer of the dentate gyrus following removal of its commissural afferents

Randall McWilliams,G. Lynch

DOI: https://doi.org/10.1002/cne.901800311

1978-08-01

The Journal of Comparative Neurology

Abstract:The inner one‐third of the dendritic region of the dentate gyrus granule cells in adult rats receives projections primarily from the commissural fibers of the contralateral hippocampus and the associational fibers of the ipsilateral hippocampus. At two to four days following the complete removal of the contralateral hippocampus, approximately 25% of the terminals in the inner molecular layer are observed degenerating. This provides an excellent model system to investigate possible terminal proliferation induced by deafferentation since (1) the experimental lesion is easily reproducible, (2) no retrograde reactions occur in the granule cells as a direct result of the lesion, (3) no shrinkage is detected in this region following commissural deafferentation, (4) the same dendritic region can be relocated precisely in each animal, and (5) the synaptic counts are highly consistent between animals.
Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom's macroglobulinaemia

P Alexander,D Flanagan,K Rege,A Foss,M Hingorani

DOI: https://doi.org/10.1038/eye.2008.193

Abstract:Purpose: Central retinal vein occlusions (CRVOs) are rarely treatable; most therapy is directed towards prevention or treatment of complications. Bilateral CRVO can be due to serum hyperviscosity, which affects 15% of all patients with Waldenstrom's macroglobulinaemia (WM). Although previously reported in a handful of cases, bilateral CRVO is a rare presenting feature. Patients and methods: Illustrated case reports of three patients presenting with bilateral CRVO due to undiagnosed WM. Results: Plasma exchange, which successfully restored vision in two patients, was followed by long-term cytotoxic therapy. Conclusions: Plasma electrophoresis should be performed in all patients with retinal vein occlusions to exclude a paraproteinaemia. In patients with bilateral venous changes, there should be a very high level of suspicion of hyperviscosity, with the possibility of effective early therapy.
Solid phase immunoradiometric assay of activated human coagulation factor IX.

V. Bom,H. Reinalda-Poot,S. Poort,R. Cupers,R. Bertina

DOI: https://doi.org/10.1016/0049-3848(87)90328-8

IF: 10.407

1987-03-01

Thrombosis Research

Abstract:
Motif Finding in Biological Sequences ∗

Ying Liao,Chang-Biau Yang,S. Shiau

Abstract:A huge number of genomic information, including protein and DNA sequences, is generated by the human genome project. Deciphering these sequences and detecting local residue patterns of multiple sequences are very difﬁcult. One of the ways to decipher these biological sequences is to detect local residue patterns from them. However, detecting unknown patterns from multiple sequences is still very difﬁcult. In this paper, we propose an algorithm, based on the Gibbs sampler method, for identifying local consensus patterns (motifs) in monomolecular sequences. We ﬁrst designed an ACO (ant colony optimization) algorithm to ﬁnd a good initial solution and a set of better candidate positions for revising the motif. Then the Gibbs sampler method is applied with these better candidate positions as the input. The required time for ﬁnding motifs using our algorithm is reduced drastically. It takes only 20% of time of the Gibbs sampler method and it maintains the comparable quality.
Teaching and learning moments: The good patient.

J. Galen Buckwalter

DOI: https://doi.org/10.1097/01.ACM.0000348385.44929.a9

Abstract:
Multimodal Imaging Characteristics and Risk Factors Analysis of Waldenström Macroglobulinemia Retinopathy

Huan Chen,Yuelin Wang,Zhengbo Xu,Donghui Li,Hong Du,Youxin Chen,Jun Feng

DOI: https://doi.org/10.1016/j.ajo.2023.03.011

IF: 5.488

2023-03-01

American Journal of Ophthalmology

Abstract:PURPOSE: To summarize the multimodal imaging features and analyze the risk factors of Waldenström macroglobulinemia retinopathy (WMR).DESIGN: Retrospective, cross-sectional study.METHODS: Patients diagnosed with Waldenström macroglobulinemia and underwent ophthalmic examination in Peking Union Medical College Hospital in the last decade were included. Multimodal imaging characteristics of WMR were summarized. Univariate and multivariate logistic regression analysis of WMR and potential systemic and ocular factors was performed.RESULTS: A total of 50 WM patients were included in this study, and 28 patients had WMR in at least one eye. WMR was found to have worse LogMAR visual acuity (VA) (0.52±0.54 vs. 0.21±0.18, p=0.009), and was characterized by tortuous retinal vessels, extensive retinal hemorrhage, and distinctive shape of macular edema, etc. In univariate analysis, the presence of WMR was significantly associated with the mean VA (LogMAR), serum RBC counts, serum PLT counts, HGB level, serum M protein, serum IgM level, and LDH (with p<0.05). In multivariate analysis, WMR was significantly correlated with M protein (adjusted OR=1.127, 95% CI 1.052-1.209, p= 0.001) and serum IgM (adjusted OR=1.059, 95% CI 1.023-1.095, p= 0.001) with the predicted AUC of 0.820 and 0.859, respectively. The optimal cut-off values were 26.2g/L for M protein, and 51.0g/L for IgM, which accounts for a sensitivity of 95.4% and 95.4%, and specificity of 64.3% and 60.7%.CONCLUSIONS: Retinopathy of WM has specific characteristics in ophthalmic examinations. Serum IgM levels and M protein are good predictors of WMR, which could attach important value of fundus examinations for WM patients.

ophthalmology
Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors.

M. Komiya,Shigehiro Asano,N. Koike,Erina Koga,J. Igarashi,S. Nakatani,Y. Isobe

DOI: https://doi.org/10.1016/j.bmcl.2011.01.012

IF: 2.94

2011-03-01

Bioorganic & Medicinal Chemistry Letters

Abstract:
The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia

Rosanna Dammacco,Walter Lisch,Tero T Kivelä,Evangelos Terpos,Efstathios Kastritis,Dario Sisto,Alberto Mavilio,Roberto Ria,Giovanni Alessio,Angelo Vacca,Franco Dammacco

DOI: https://doi.org/10.1080/09273948.2021.1933068

Abstract:Purpose: To investigate the ocular manifestations in 91 Waldenström's macroglobulinemia (WM) patients. Methods: Retrospective, cross-sectional, observational analysis. Results: Ocular impairments, detected in 19 patients, included flame-shaped hemorrhages, venous sausaging, papilledema, macular detachments, or central retinal vein occlusion in 16 patients; paraproteinemic keratopathy in 2; and a CANOMAD syndrome in 1. Best-corrected visual acuity was ≥0.5 logMAR units in 11 of 38 eyes. Intraocular pressure was increased in seven eyes. Genetic analysis in seven patients showed a mutation in the MYD88 gene in six patients and a nonsense mutation in the CXCR4 gene in five patients. Plasmapheresis followed by chemotherapy with or without the addition of rituximab resulted in improvement or normalization of the ophthalmological findings in 15 patients. Conclusion: The ocular manifestations of WM are protean and potentially sight threatening. Recent advances in genomic profiling and chemotherapy have remarkably improved the hematological and ophthalmological outcomes of these patients.
Anesthetics block excitation with various effects on inhibition in MRF neurons

K. Shimoji,H. Fujioka,T. Ebata

DOI: https://doi.org/10.1016/0006-8993(84)90830-8

IF: 3.61

1984-03-12

Brain Research

Abstract:
Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only

Michal Blau-Most,Raz Gepstein,Alexander Rubowitz

DOI: https://doi.org/10.1016/j.ajoc.2018.08.006

2018-08-29

Abstract:Purpose: To describe the clinical presentation and imaging features of a patient presenting with bilateral central retinal vein occlusion (CRVO), who was subsequently diagnosed with hyperviscosity retinopathy due to B cell lymphoproliferative disease, and had a good response to systemic immunosuppressive therapy. Observations: A clinical case report of an 87-year-old woman who presented with bilateral CRVO. Visual acuity, clinical examination, spectral domain optical coherence tomography (SD-OCT), color fundus photography and systemic evaluation were obtained. Ocular examination at presentation revealed bilateral CRVO, and OCT examination revealed significant central macular edema bilaterally. Six months after the diagnosis of hyperviscosity retinopathy and administration of systemic cyclophosphamide immunosuppressive therapy for B cell lymphoproliferative disease, most of the retinal hemorrhages resolved and partial resolution of the macular edema in the left eye was observed. Conclusion and importance: This case describes the association between bilateral simultaneous CRVO and hyperviscosity. Under unique circumstances our patient received systemic therapy alone, without plasmapheresis. Although only limited therapy was applied, she didn't have deterioration or recurrent events; she had a small improvement in her macular edema and a significant improvement in her systemic functional state as well as reduction in her monoclonal IGM level.
Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies

Marion R. Munk,Lala Ceklic,Richard Stillenmunkes,Varun Chaudhary,Nadia Waheed,Jay Chhablani,Marc D. de Smet,Anne Tillmann

DOI: https://doi.org/10.3390/diagnostics14171983

IF: 3.6

2024-09-08

Diagnostics

Abstract:Retinal vein occlusion (RVO) is a significant cause of vision loss, characterized by the occlusion of retinal veins, leading to conditions such as central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). Macular edema (ME), a prevalent consequence of RVO, is the primary cause of vision impairment in affected patients. Anti-VEGF agents have become the standard treatment, showing efficacy in improving visual acuity (VA) and reducing ME. However, a subset of patients exhibit a suboptimal response to anti-VEGF therapy, necessitating alternative treatments. Corticosteroids, which address inflammatory pathways implicated in ME, have shown promise, particularly in cases resistant to anti-VEGF. This review aims to identify biomarkers that predict treatment response to corticosteroids in RVO-associated ME, utilizing multimodal imaging and cytokine assessments. Baseline imaging, including SD-OCT and OCT-A, is essential for evaluating biomarkers like hyperreflective foci (HRF), serous retinal detachment (SRF), and central retinal thickness (CRT). Elevated cytokine levels, such as IL-6 and MCP-1, correlate with ME severity and poor anti-VEGF response. Early identification of these biomarkers can guide timely transitions to corticosteroid therapy, potentially enhancing treatment outcomes. The practical conclusion of this review is that integrating biomarker assessment into clinical practice enables personalized treatment decisions, allowing for earlier and more effective management of RVO-associated ME by transitioning patients to corticosteroid therapy when anti-VEGF agents are insufficient. Advanced diagnostics and machine learning may further refine personalized treatment strategies, improving the management of RVO-associated ME.

medicine, general & internal
Study on volume production of uniform wafer-level micro glass cavities by a chemical foaming process (CFP)

Yu Zou,J. Shang,Yu Ji,Li Zhang,Chiming Lai,Dong Chen,Kim-Hui Chen

DOI: https://doi.org/10.1109/ICEPT.2013.6756565

2013-08-01

Abstract:In this paper, an improved chemical foaming process (CFP) for wafer-level glass cavities will be demonstrated for volume production in a clean room. First of all, suitable foaming agents transferring techniques are investigated to avoid powder pollution to the chips in a clean room. In addition, the precise controlling of the sizes of the glass cavities is studied theoretically and experimentally. The shapes, morphology and sizes of the glass cavities formed by the improved CFP are characterized by AFM and digital 3D microscopy. A theoretical model for precisely predicting the final shapes and sizes are established. Moreover, glass cavities with uniform structures and precisely controlled sizes at a 4-inch wafer are prepared successfully. The improved CFP will provide a novel volume-production technique for micro-machining of glass, which has many applications in MEMS and MOEMS.
Bilateral reversible optic neuropathy as the first sign of Waldenström macroglobulinema

Yoshiaki Shimada,Yoshiki Akatsuka,Kazuya Nokura

DOI: https://doi.org/10.3205/oc000240

2024-06-25

Abstract:Objective: To report a case of bilateral reversible optic neuropathy as the first sign of Waldenström macroglobulinemia (WM). Methods: Observational case report. Results: A 52-year-old man had a sudden loss of vision in the left eye. Examinations revealed the presence of a serum monoclonal immunoglobulin (IgM kappa) in the serum. Even after a session of steroid pulse therapy, optic neuropathy became bilateral and then resolved almost completely after 4 months. The condition progressed to WM with multiorgan lesions years later. There was no evidence of optic neuropathy recurrence. The literature revealed two cases of monoclonal gammopathy (MG): a 64-year-old man with multiple myeloma (MM) with IgA lambda and a 51-year-old man with MM with IgG kappa. These cases have similar conditions: 1) visual reduction as an initial symptom of MG, 2) bilateral involvement, 3) no sign of central nervous system (CNS) infiltration shown by normal brain magnetic resonance images, and 4) recovery to a visual acuity of ≥1.0 bilaterally with no reoccurrence. The excessive Igs or B-cell hyperactivity may activate an autoimmune mechanism that reversibly interferes with the bilateral optic nerves. Conclusion: Bilateral optic neuropathy was the initial symptom of WM. There was no evidence of CNS infiltration; it recovered and then did not reoccur. The pathogenesis remained unknown, but two cases of MG were reported in the literature with remarkably similar conditions.
Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion

Yoshio Hirano,Norihiro Suzuki,Taneto Tomiyasu,Ryo Kurobe,Yusuke Yasuda,Yuya Esaki,Tsutomu Yasukawa,Munenori Yoshida,Yuichiro Ogura

DOI: https://doi.org/10.3390/jcm10030405

IF: 3.9

2021-01-21

Journal of Clinical Medicine

Abstract:The technologies of ocular imaging modalities such as optical coherence tomography (OCT) and OCT angiography (OCTA) have progressed remarkably. Of these in vivo imaging modalities, recently advanced OCT technology provides high-resolution images, e.g., histologic imaging, enabling anatomical analysis of each retinal layer, including the photoreceptor layers. Recently developed OCTA also visualizes the vascular networks three-dimensionally, which provides better understanding of the retinal deep capillary layer. In addition, ex vivo analysis using autologous aqueous or vitreous humor shows that inflammatory cytokine levels including vascular endothelial growth factor (VEGF) are elevated and correlated with the severity of macular edema (ME) in eyes with retinal vein occlusion (RVO). Furthermore, a combination of multiple modalities enables deeper understanding of the pathology. Regarding therapy, intravitreal injection of anti-VEGF drugs provides rapid resolution of ME and much better visual improvements than conventional treatments in eyes with RVO. Thus, the technologies of examination and treatment for managing eyes with RVO have progressed rapidly. In this paper, we review the multimodal imaging and therapeutic strategies for eyes with RVO with the hope that it provides better understanding of the pathology and leads to the development of new therapies.

medicine, general & internal
Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia

Marcel N Menke,Gilbert T Feke,J Wallace McMeel,Steven P Treon

DOI: https://doi.org/10.1167/iovs.07-1254

Abstract:Purpose: Waldenström's macroglobulinemia (WM) is characterized by an overproduction of immunoglobulin M (IgM), which can lead to a hyperviscosity syndrome (HVS) and HVS-related retinopathy. Plasmapheresis is known to reduce serum viscosity (SV) and IgM levels. The purpose of this study was to investigate the effects of plasmapheresis on HVS-related retinopathy and retinal hemodynamic parameters in patients with WM. Methods: Nine patients with HVS due to WM were studied. SV and plasma IgM levels were measured before and after plasmapheresis treatment. The patients were evaluated for HVS-related retinopathy, and hemodynamic changes in a major temporal retinal vein by laser Doppler, before and after plasmapheresis. Results: Plasmapheresis resulted in significant reductions in serum IgM (46.5% +/- 18.0%, mean +/- SD; P = 0.0009) and SV (44.7% +/- 17.3%, P = 0.002). HVS-related retinopathy improved in all patients after plasmapheresis. After treatment, the venous diameter decreased in each patient by an average of 15.3% +/- 5.8% (P = 0.0001). A significant (P = 0.0004) 55.2% +/- 22.5% increase in retinal venous blood speed accompanied the decreases in diameter. There was no significant change in the retinal blood flow rate after treatment. The percentage decreases in SV in the patients were significantly correlated with the percentage decreases in venous blood column diameter (P = 0.031, R(2) = 0.51). Conclusions: HVS triggers a distinctive retinopathy with a central retinal vein occlusion (CRVO)-like appearance. However, the retinal blood flow is not decreased as in CRVO, but remains at normal levels. Plasmapheresis is effective in reversing HVS-related retinopathy and in reducing abnormal venous dilatation.
Novel configurations of type I and II CRISPR-Cas systems in Corynebacterium diphtheriae.

V. Sangal,Peter C. Fineran,P. Hoskisson

DOI: https://doi.org/10.1099/mic.0.070235-0

2013-10-01

Microbiology

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPRs) are major barriers to recombination through recognition of invading nucleic acids, such as phage and plasmids, and promoting their degredation through the action of CRISPR associated (Cas) proteins. The genomic comparison of 17 Corynebacterium diphtheriae strains led to the identification of three novel CRISPR-Cas system variants, based on the Type II (Type II-C) or type I-E systems. The type II-C system was the most common (11/17 isolates) but it lacked the csn2 and cas4 genes that are involved in spacer acquisition. We also identified that this variant type II-C CRISPR-Cas system is present in other bacteria, and the first system was recently characterized in Neisseria meningitidis. In the remaining isolates, the type II-C system was replaced by a variant of type I-E (I-E-a), where the repeat arrays are inserted between the cas3 and cse1 genes. Three isolates with the type II-C system also possess an additional variant of type I-E (I-E-b), elsewhere in the genome, that exhibits a novel divergent gene organization within the cas operon. The nucleotide sequences of the palindromic repeats and the cas1 gene were phylogenetically incongruent to the core genome. The G+C content of the systems is lower (46.0-49.5 mol%) than the overall DNA G+C content (53 mol%), and they are flanked by mobile genetic elements, providing evidence that they were acquired in three independent horizontal gene transfer events. The majority of spacers lack identity with known phage or plasmid sequences, indicating that there is an unexplored reservoir of corynebacteriophages and plasmids. These novel CRISPR-Cas systems may represent a unique mechanism for spacer acquisitions and defence against invading DNA.
Analyze of Factors and Prognosis of Eyes Lost to Follow-Up in Retinal Vein Occlusive Disease Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy

Xiaoying Huang,Minming Zheng,Jiatao Lu,Xi Wang,Zheng

DOI: https://doi.org/10.1186/s12886-023-03018-9

IF: 2.086

2023-01-01

BMC Ophthalmology

Abstract:Background: Patients with macular edema (ME) secondary to retinal vein occlusion (RVO) who received at least one intravitreal injection of anti-vascular endothelial growth factor therapy (VEGF) and lost to follow-up (LTFU) for more than six months were analyzed to investigate the factors contributing to the LTFU and the prognosis. Method: This was a retrospective, single-center study to analyze the causes and prognosis of LTFU over six months in RVO-ME patients treated with intravitreal anti-VEGF injections at our institution from January 2019 to August 2022 and to collect patients' baseline characteristics along with the number of injections before LTFU, primary disease, best corrected visual acuity (BCVA) before LTFU and after return visit, central macular thickness (CMT), months before LTFU and after LTFU, reasons for LTFU, and complications, to analyze the factors affecting visual outcome at a return visit. Results: This study included 125 patients with LTFU; 103 remained LTFU after six months, and 22 returned after LTFU. The common reason for LTFU was "no improvement in vision" (34.4%), followed by "transport inconvenience" (22.4%), 16 patients (12.8%) were unwilling to visit the clinic, 15 patients (12.0%) had already elected to seek treatment elsewhere, 12 patients (9.6%) were not seen in time due to the 2019-nCov epidemic, and 11 patients (8.8%) cannot do it due to financial reasons. The number of injections before LTFU was a risk factor for LTFU ( P < 0.05). LogMAR at the initial visit ( P < 0.001), CMT at the initial visit ( P < 0.05), CMT before the LTFU ( P < 0.001), and CMT after the return visit ( P < 0.05) were influential factors for logMAR at the return visit. Conclusion: Most RVO-ME patients were LTFU after anti-VEGF therapy. Long-term LTFU is greatly detrimental to the visual quality of patients; thus, the management of RVO-ME patients in follow-up should be considered.
Providing unrestricted VCR functions in multicast video-on-demand servers

Emmanuel L. Abram-Profeta,K. Shin

DOI: https://doi.org/10.1109/MMCS.1998.693626

1998-06-28

Abstract:Full support for interactive VCR functions can be achieved only by dedicating a channel for each customer. Unfortunately, channel dedication should not be used in a multicast video-on-demand (VoD) system, because it degrades scalability; and hence economical viability, which is usually achieved by multicasting videos. The authors, therefore, propose and evaluate a fully-interactive, yet scalable, on-demand service in multicast VoD systems. In the proposed framework, support for interactive operations is provided by (1) allocating a fraction of the VoD-server's channel capacity to handle interactive operations which would otherwise be blocked, and (2) using partial caching of programs in customers' premise equipment (CPE) to merge customers back in synchronization with broadcast channels. Their evaluation results indicate that batching policies under the proposed framework can make an attractive tradeoff between scalability and customers' QoS.
Nina Fedoroff

E. Friedberg

DOI: https://doi.org/10.1038/nrm2511

Abstract:
Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up

Emilia Maggio,Francesco Bauci,Antonio Polito,Fabrizio Arena,Grazia Pertile

DOI: https://doi.org/10.1186/s12886-024-03438-1

IF: 2.086

2024-04-25

BMC Ophthalmology

Abstract:Abstract Background Vitreoretinal lymphoma (VRL) still represents a diagnostic challenge for retinal specialists. Early diagnosis and treatment are critical for a better prognosis. Several diagnostic tools have proven helpful in the identification of VRL abnormalities. However, swept-source OCT angiography (SS-OCT-A) findings and their long-term follow-up are yet to be explored. Case presentation a 42-year-old man presented with blurred vision in his left eye for 2 weeks. He denied any systemic symptoms. A multimodal imaging examination was performed, raising the clinical suspicion of VRL and guiding the ensuing diagnostic procedures. The patient underwent treatment and at the last FU visit three years later, no disease signs were present on fundus examination, nor on oncologic evaluation. Some novel SS-OCT-A features were identified, and uncommonly reported findings were examined over a long-term follow-up. At baseline multiple hyperreflective alterations were detected on the enface outer retina slabs and choriocapillary analysis revealed low reflectance areas in the foveal and parafoveal areas. One month after the first presentation, multiple hyperreflective retinal lesions in a vertical shape were detected on OCT which appeared on midretinal slabs of enface SS-OCT-A as hyperreflective spots mainly located near second-order retinal vessels. These alterations remarkably reduced after treatment. Conclusion SS-OCT-A may be a useful imaging technique in the detection of VRL, providing ophthalmologists additional findings that assist the diagnosis and follow-up of this disease. This may prove useful for a more timely and precise diagnosis, prompt therapy, and treatment response monitoring. The original aspects found in this case may provide grounds for future studies, ultimately fostering a better understanding of the disease.

ophthalmology

Effects of experimental coarctation of the aorta on atheroma in sheep.

Terminal proliferation and synaptogenesis following partial deafferentation: The reinnervation of the inner molecular layer of the dentate gyrus following removal of its commissural afferents

Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom's macroglobulinaemia

Solid phase immunoradiometric assay of activated human coagulation factor IX.

Motif Finding in Biological Sequences ∗

Teaching and learning moments: The good patient.

Multimodal Imaging Characteristics and Risk Factors Analysis of Waldenström Macroglobulinemia Retinopathy

Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors.

The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia

Anesthetics block excitation with various effects on inhibition in MRF neurons

Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only

Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies

Study on volume production of uniform wafer-level micro glass cavities by a chemical foaming process (CFP)

Bilateral reversible optic neuropathy as the first sign of Waldenström macroglobulinema

Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion

Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia

Novel configurations of type I and II CRISPR-Cas systems in Corynebacterium diphtheriae.

Analyze of Factors and Prognosis of Eyes Lost to Follow-Up in Retinal Vein Occlusive Disease Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy

Providing unrestricted VCR functions in multicast video-on-demand servers

Nina Fedoroff

Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up